Moberg Pharma: A very promising Norwegian launch - Redeye

Moberg Pharma successfully launched Teclara in Sweden last year, and the early initial feedback from Norway based on April and May is powerful, indicating that Teclara is matching (April) or even topping (May) the Swedish introduction in 2024

Länk till analysen i sin helhet: https://www.redeye.se/research/1115702/moberg-pharma-a-very-promising-norwegian-launch?utm_source=finwire&utm_medium=RSS